title: Availability of EGFR mutation status at first oncology consultation for advanced non-squamous non-small cell lung cancer patients. A pilot experience from the Christie.
authors.affiliation: Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
authors.forename: M
authors.initials: M
authors.lastname: Evans
authors.forename: Y
authors.initials: Y
authors.lastname: Summers
authors.forename: P
authors.initials: P
authors.lastname: Taylor
authors.forename: M
authors.initials: M
authors.lastname: Harris
authors.forename: N
authors.initials: N
authors.lastname: Bayman
authors.forename: C
authors.initials: C
authors.lastname: Faivre-Finn
authors.forename: H
authors.initials: H
authors.lastname: Sheikh
authors.forename: P
authors.initials: P
authors.lastname: Burt
authors.forename: F
authors.initials: F
authors.lastname: Blackhall
authors.forename: R
authors.initials: R
authors.lastname: Califano
mesh_terms: D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis* / Q000235:genetics; D004252:DNA Mutational Analysis; D055088:Early Detection of Cancer; D005260:Female; D018773:Genes, erbB-1 / Q000235:genetics*; D006801:Humans; D033183:Interdisciplinary Communication; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000235:genetics; D008297:Male; D008495:Medical Oncology; D009154:Mutation / Q000235:genetics*; D009367:Neoplasm Staging; D010865:Pilot Projects; D012017:Referral and Consultation; D013997:Time Factors; D006113:United Kingdom
keywords: Adenocarcinoma; EGFR activating mutations; Mutation analysis; Non-small cell lung cancer